Can the effects of vasoactivity of molecular hemoglobin-based plasma expanders be ignored?
Tsai
Amy G
AG
Cabrales
Pedro
P
D000818:Animals; D001802:Blood Substitutes / Q000494:pharmacology*; D006454:Hemoglobins / Q000494:pharmacology*; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013552:Swine; D014666:Vasomotor System / Q000187:drug effects*
D001802:Blood Substitutes; D006454:Hemoglobins; C096798:HBOC 201